U.S. Customs and Border Protection August 28, 2017 – Federal Register Recent Federal Regulation Documents

Notice of Issuance of Final Determinations Concerning Certain Pharmaceutical Products
Document Number: 2017-18205
Type: Notice
Date: 2017-08-28
Agency: Department of Homeland Security, U.S. Customs and Border Protection
This document provides notice that U.S. Customs and Border Protection (``CBP'') has issued six final determinations concerning the country of origin of certain pharmaceutical products produced by Lupin Pharmaceuticals, Inc. Based upon the facts presented, CBP has concluded that the country of origin of the meloxicam tablets is Italy for purposes of U.S. Government procurement, that the country of origin of the bimatoprost ophthalmic solution is Taiwan for purposes of U.S. Government procurement, that the country of origin of the niacin ER tablets is Belgium or Switzerland for purposes of U.S. Government procurement, that the country of origin of the calcium acetate capsules is the Netherlands for purposes of U.S. Government procurement, that the country of origin of the quinine sulfate capsules is Germany for purposes of U.S. Government procurement, and that the country of origin of the pravastatin sodium tablets is Taiwan for purposes of U.S. Government procurement.
Notice of Issuance of Final Determination Concerning Country of Origin of Tablet Computers for Health Mobile and Hub Platforms
Document Number: 2017-18202
Type: Notice
Date: 2017-08-28
Agency: Department of Homeland Security, U.S. Customs and Border Protection
This document provides notice that U.S. Customs and Border Protection (``CBP'') has issued a final determination concerning the country of origin of tablet computers known as Vivify Health Mobile and Hub Platforms. Based upon the facts presented, CBP has concluded in the final determination that for purposes of U.S. Government procurement in the installation of proprietary software on tablet computer does not substantially transform the imported tablet computers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.